INSCARE Trademark

Trademark Overview


On Wednesday, March 2, 2022, a trademark application was filed for INSCARE with the United States Patent and Trademark Office. The USPTO has given the INSCARE trademark a serial number of 97291668. The federal status of this trademark filing is REGISTERED as of Tuesday, June 20, 2023. This trademark is owned by Shenzhen Lifotronic Technology Co., Ltd.. The INSCARE trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of COVID-19; Chemical preparations for pharmaceutical or medical purposes, namely, for use in disease detection, namely, SARS-CoV-2 Antigen Rapid Test; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, SARS-CoV-2 Antigen Rapid Test; Diagnostic preparations for medical and veterinary use; Medical diagnostic test strips for use in the field of blood glucose level testing; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis; Mixed biological preparations for the prevention and treatment of infectious diseases
inscare

General Information


Serial Number97291668
Word MarkINSCARE
Filing DateWednesday, March 2, 2022
Status700 - REGISTERED
Status DateTuesday, June 20, 2023
Registration Number7088515
Registration DateTuesday, June 20, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Description of MarkThe mark consists of the literal element "INSCARE" in a stylized font.
Goods and ServicesBiological preparations for the treatment of COVID-19; Chemical preparations for pharmaceutical or medical purposes, namely, for use in disease detection, namely, SARS-CoV-2 Antigen Rapid Test; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, SARS-CoV-2 Antigen Rapid Test; Diagnostic preparations for medical and veterinary use; Medical diagnostic test strips for use in the field of blood glucose level testing; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis; Mixed biological preparations for the prevention and treatment of infectious diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 7, 2022
Primary Code005
First Use Anywhere DateThursday, April 20, 2023
First Use In Commerce DateThursday, April 20, 2023

Trademark Owner History


Party NameShenzhen Lifotronic Technology Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressShenzhen 518110
CN

Party NameShenzhen Lifotronic Technology Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShenzhen 518110
CN

Party NameShenzhen Lifotronic Technology Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShenzhen 518110
CN

Trademark Events


Event DateEvent Description
Tuesday, June 20, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 20, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, May 17, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 16, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 15, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, April 24, 2023USE AMENDMENT FILED
Friday, May 12, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 24, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, March 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 1, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, December 1, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 1, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, December 1, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 30, 2022ASSIGNED TO EXAMINER
Monday, March 7, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, March 7, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, March 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 5, 2022NEW APPLICATION ENTERED